You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NAMS Buy Disclosure
Davidson Michael H. · SEC Form 4 · Filed Sep 15, 2026
Buy
Calculated transaction value
$226.5K
Davidson Michael H. Chief Executive Officer
NAMS
Transaction date
Sep 14, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 1 day later
NAMS daily price context
Close on/before transaction
$22.36
Sep 14, 2026
First close after public filing
$21.18
Sep 16, 2026
30-day return after filing
-2.64%
Through Oct 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 10,000 shares @ $22.65
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-391985
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$226.5K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Newamsterdam Pharma Co N.v. NAMS Current | Buy | Sep 14, 2026 | $226.5K |